New Publication in the International Journal of Molecular Sciences MDPI
A comprehensive review on the evolution and applications of lentiviral vectors, reinforcing VIVEbiotech’s scientific and technological leadership.
VIVEbiotech is pleased to announce the publication of its latest review article titled “Lentiviral Vectors: From Wild-Type Viruses to Efficient Multi-Functional Delivery Vectors” in the International Journal of Molecular Sciences (MDPI).
This open-access review provides an in-depth analysis of the evolution of lentiviral vectors into versatile tools for ex-vivo and in-vivo gene therapy, vaccines, and gene editing. It also discusses strategies to control the molecular mechanisms involved in their production.
At VIVEbiotech, we combine manufacturing expertise with a strong scientific foundation in virology and applied research. This publication reflects the depth of our R&D activities and reaffirms our position as a trusted partner for complex lentiviral projects.
This milestone is shared during the European Society of Gene and Cell Therapy (ESGCT) Annual Congress held this week in Seville, highlighting our commitment as both scientific experts and manufacturers in the lentiviral field.
Watch the full video on our profile on LinkedIn or YouTube.
Read the full open-access article here: https://pubmed.ncbi.nlm.nih.gov/40943418/